Shanghai Pharmaceutical (Group) Co., Ltd. (referred to as "Shanghai Pharmaceutical Group" for short) was formerly Shanghai Pharmaceutical (Group) Corporation, which was reorganized and established by the former Shanghai Pharmaceutical Administration 1996 in June 2002, and further restructured into a diversified investment Shanghai Pharmaceutical (Group) Co., Ltd. in September 2002. In July 2008, the State-owned Assets Supervision and Administration Commission of Shanghai adjusted the equity of Shanghai Pharmaceutical Group, and adjusted the 30% equity of Shanghai Pharmaceutical (Group) Co., Ltd. held by Shanghai Huayi (Group) Company and Shanghai Industrial Investment (Group) Co., Ltd. to Shanghai Shangshi (Group) Co., Ltd.
Shanghai Pharmaceutical Group has developed into a large enterprise group integrating science, industry and trade, with nearly 30,000 employees and registered capital of 365,438+58 million yuan. It is the largest pharmaceutical enterprise with the most complete industrial chain and marketing network in China, ranking among the top 500 Chinese enterprises. It is a global pharmaceutical partner of China 2065,438+00 Shanghai World Expo.